Proceedings of the National Academy of Sciences, Volume 123, Issue 39, September 2026. SignificanceAntibody-mediated diseases comprise many different clinical disease entities, and affect more than 10% of the human population. Plasma cells have emerged as a promising therapeutic target for these diseases. However, currently available …